SITC is pleased to announce the recipients of three 2018 Fellowship Awards, to support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of novel research.
The SITC Fellowship Awards program was established through the society’s Forward Fund, which has committed more than $2 million in Fellowship Award opportunities to deserving young investigators since 2014.
The award recipients will be honored during a ceremony at the society’s 33rd Annual Meeting on Saturday, Nov. 10, 2018, at the Walter E. Washington Convention Center in Washington, D.C.
The 2018 SITC Fellowship Award recipients are:
SITC-Bristol-Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship Award
Recipient: David Liu, MD, MPH, MS, Dana-Farber Cancer Institute
Project Title: “Dissecting Differential Response to Immunotherapy in Melanoma through Clinical Computational Oncology”
Award Amount: $200,000 (two years)
Sponsored by
Made possible by an educational grant from Bristol-Myers Squibb.
SITC-AstraZeneca Postdoctoral Cancer Immunotherapy in Combination Therapies Clinical Fellowship Award
Recipient: Bryan D. Choi, MD, PhD, Massachusetts General Hospital and Harvard Medical School
Project Title: “Combination Immunotherapy with Chimeric Antigen Receptor T cells and Bispecific T-cell Engagers for Glioblastoma”
Award Amount: $100,000 (one year)
Sponsored by
Made possible by an educational grant from AstraZeneca Pharmaceuticals LP.
SITC-Merck Cancer Immunotherapy Clinical Fellowship Award
Recipient: Kelly G. Paulson, MD, PhD, Fred Hutchinson Cancer Research Center
Project Title: “Turning immunotherapy responses into immunotherapy cures for the virus-associated Merkel cell carcinoma”
Award Amount: $100,000 (one year)
Sponsored by
Made possible by an educational grant from Merck & Co., Inc.